The Brutalist Report - business
- MicroStrategy 'Stretch'-ed it too far with new product launch [240d]
- Trump's company is shockingly one of the top holders of Bitcoin [240d]
- Stock market today: Dow, S&P 500, Nasdaq futures trade flat as Wall Street braces for Big Tech earnings [240d]
- Stock market today: Dow, S&P 500, Nasdaq futures slip as Wall Street braces for the next wave of earnings [240d]
- Stock market today: Dow, S&P 500, Nasdaq futures wobble amid wave of earnings as tariffs bite GM profit [240d]
- This High-Yield Dividend Stock (8.3%) Has Analysts Saying ‘Strong Buy’ — Should You? [240d]
- Chip giant TSMC is the newest member of the $1 trillion market-cap club [240d]
- Why AT&T Stock Jumped Today [240d]
- ‘Rich Dad Poor Dad’ author tells Americans to stop saving dollars [240d]
- Over 99% of XRP holders are in profit [240d]
- 3iQ bets on regulated crypto access as institutional demand heats up [240d]
- Ready to retire in 5 years? Here’s your checklist [240d]
- Is A Bitcoin and Ethereum Treasury Company Bubble Forming? [240d]
- AstraZeneca Plans to Invest $50 Billion in U.S. by 2030 [240d]
- Universal Music Group Files for Public Offering [240d]
- SoftBank and OpenAI’s $500 Billion AI Project Struggles to Get Off Ground [240d]
- Trader dumps asset after turning $100 into $2M [240d]
- Cotton Falls to Start the Week [240d]
- Corn Gives Back Gains as Crop Ratings Hold Steady [240d]
- The Stock Market’s Momentum Is Stalling With Mag 7 Earnings on Deck [240d]
- Organon & Co. (OGN) Restructures, Expands in Women’s Health and Biosimilars [240d]
- Sanofi (SNY) Expands Rare Disease Reach With $9.5B Blueprint Deal [240d]
- United Therapeutics Corporation (UTHR) Completes Phase 3 Enrollment for Promising PAH Drug Ralinepag [240d]
- Biogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome [240d]
- Merck & Co., Inc. (MRK) Breaks Ground on $1B Biologics Hub to Boost KEYTRUDA Production [240d]
- AstraZeneca PLC (AZN)’s Datroway Wins FDA Nod for Lung Cancer Breakthrough [240d]
- Alkermes plc (NASDAQ:ALKS) Launches Phase II Trial of ALKS 2680 for Idiopathic Hypersomnia [240d]
- Kisqali Emerges as Novartis AG (NVS) Blockbuster with Record Q2 Growth [240d]
- Johnson & Johnson (JNJ)’s Pasritamig Shows Breakthrough Promise in Prostate Cancer [240d]
- Activist Elliott grows stake in Equinix, holds talks with company [240d]
- Prestige Consumer Healthcare Inc. (PBH) Reinvents Retail Strategy for the Digital Age [240d]
- Private Credit ETF Flows Catch Up: State Street's Paglia [240d]
- Universal Music confidentially files for US listing [240d]
- Podcast: Stocks Edge Higher as Earnings Season Ramps Up [240d]
- How to file a homeowners insurance claim [240d]
- AstraZeneca to invest $50B in US economy by 2030 [240d]
- Astera Labs Stocks and 2 More Recent IPOs That Look Strong Right Now [240d]
- Brazil planemaker Embraer ends Q2 with record $30 billion backlog [240d]
- AstraZeneca unveils $50 billion US investment as pharma tariff threat looms [240d]
- S&P 500 Gains and Losses Today: Verizon Shares Surge; Natural Gas Stocks Fall [240d]
- Here's How Much Traders Expect Tesla Stock To Move After Earnings Wednesday [240d]
- AstraZeneca announces $50 billion US manufacturing investment, matching its big pharma peers [240d]
- The surprising details of fashion entrepreneur Christine Hunsicker’s fraud indictment [240d]
- W.R. Berkley Profit Rises Despite Continued Surge in Catastrophe Losses [240d]
- Solana soars as DeFi amasses 999,999 SOL tokens on its balance sheet [240d]
- Why Archer Aviation Stock Plummeted Today [240d]
- The Dollar Pushes Lower. These ETFs Gain Most When It Falls. [240d]
- G-III Brings War of Words to PVH in Licensing Lawsuit [240d]
- Top analyst predicts new S&P 500 stock could soon double amid latest move [240d]
- Trading Day: Equity optimism hard to quell [240d]
- As Trump Bets Big on Rare Earth Magnets, This Hidden-Gem Stock Could Soar [240d]
- Stock Tokens Are Coming. Schwab, Interactive Brokers CEOs Don’t Like It. [240d]
- $356M in Assets Leaves DIA as Dow Falls on EU Tariff Demands [240d]
- No new articles in the Past 3 Hours.
- No new articles in the Past 3 Hours.
- No new articles in the Past 3 Hours.
- No new articles in the Past 3 Hours.
Previous Day